FRNM · FREENOME INC

Freenome, Inc., a biotechnology company, develops blood-based screening tests to detect cancer in the United States. The company offers an early cancer detection platform that integrates multiomics, artificial intelligence, and machine learning to uncover complex biological signals associated with cancer. It develops SimpleScreen™ CRC, a blood-based test, including a test for colorectal cancer screening, as well as tests for multi-cancer and multi-disease detection, such as lung, breast, cervical, liver, pancreatic, and esophageal cancers. The company was founded in 2014 and is headquartered in Brisbane, California.

3300 Marina Boulevard, Brisbane, CA, 94005, United States
Diagnostics & Research
Healthcare

Market Cap

1.125B

52 Wk Range

$9.71 - $17.50

Previous Close

$10.09

Open

$10.20

Volume

523,799

Day Range

$9.74 - $10.56

Enterprise Value

897.8M

Cash

N/A

Avg Qtr Burn

N/A

Insider Ownership

25.01%

Institutional Own.

69.20%

Qtr Updated

N/A